Posts

Zealand Pharma says obesity drug deal with Roche will h...

Danish biotech is developing petrelintide in partnership with Swiss pharma group

New treatment against Duchenne muscular dystrophy

EMA has recommended granting a conditional marketing authorisation in the Europe...

EMA business hours over Easter holiday period

EMA's office is closed from 18:00 on Wednesday 16 April 2025 to 08:30 on Tuesday...

Tackling vulnerabilities in the supply chain of radioph...

EMA and the Heads of Medicines Agencies (HMA), through the Executive Steering Gr...

Management Board meeting on possible renewal of Executi...

EMA’s Management Board has unanimously recommended the renewal of its Executive ...

Meeting highlights from the Committee for Medicinal Pro...

16 new medicines recommended for approvalEMA’s human medicines committee (CHMP) ...

EMA closed 1 May

The European Medicines Agency's (EMA) office is closed from 18:00 on Wednesday 3...

FDA Roundup: March 7, 2025

The U.S. Food and Drug Administration is providing an at-a-glance summary of new...

FDA Roundup: March 18, 2025

The U.S. Food and Drug Administration is providing an at-a-glance summary of new...

FDA Roundup: March 14, 2025

The U.S. Food and Drug Administration is providing an at-a-glance summary of new...

FDA Roundup: March 21, 2025

The U.S. Food and Drug Administration is providing an at-a-glance summary of new...

HHS, FDA Announce Chemical Contaminants Transparency To...

Under the leadership of HHS Secretary Robert F. Kennedy, Jr., the FDA unveiled a...

FDA Commissioner Makary Announces New Policy on Individ...

FDA Commissioner Martin A. Makary, M.D., M.P.H. announces a policy directive tha...

ANI Pharmaceuticals Announces FDA Approval for Expansio...

BAUDETTE, Minn., March 14, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (N...

FDA Approves Novartis Radioligand Therapy Pluvicto for ...

Basel, March 28, 2025 – Novartis announced today that the US Food and Drug Admin...

Bionpharma Inc. Issues Voluntary Nationwide Recall of A...

Audience: Healthcare Provider, Pharmacy, Consumer September 17, 2024 – Princeton...

C&A Naturistics Issues Voluntary Nationwide Recall of A...

Audience: Consumers October 16, 2024 – National City, CA, C&A Naturistics is vol...

FDA Requires Guillain-Barré Syndrome (GBS) Warning in t...

Audience: Patient, Health Care Professional, Pharmacy, Immunology, Pulmonology I...

Astellas Issues Recall of One Lot of Prograf 0.5 mg and...

Audience: Healthcare Provider, Pharmacy, Consumer NORTHBROOK, IL, Dec. 23, 2024 ...

Alcon Laboratories Issues Voluntary Nationwide Recall o...

Audience: Healthcare Provider, Pharmacy, Consumer December 21, 2024 – Fort Worth...

FDA Warns Health Care Professionals Not to Use Epinephr...

Audience: Health Care Professionals January 16, 2025 -- FDA is warning health ca...

Provepharm Inc. Issues Recall of One Lot of Phenylephri...

Audience: Pharmacy, Consumer January 24, 2025 – Collegeville, Pennsylvania, Prov...

Drug Safety Communication: Copaxone, Glatopa (glatirame...

Audience: Patient, Caregiver, Health Care Professional, Pharmacy, Neurology ISSU...

Alvogen Issues Voluntary Nationwide Recall for One Lot ...

Audience: Consumer, Health Professional, Pharmacy January 31, 2025 – Morristown,...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.